Inhibikase Therapeutics (IKT) Stock Chart & Stock Price History $1.66 +0.02 (+1.22%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$1.66 0.00 (0.00%) As of 10/3/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Inhibikase Therapeutics Stock Price Performance The Inhibikase Therapeutics (IKT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 31.75%, with a year-to-date return of -48.92%. In the past month, the stock has decreased 2.92%, reflecting recent market activity. As of the latest close, Inhibikase Therapeutics traded at $1.66 with a market cap of $123.70 million and volume of 75,316 shares. Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+8.50%1 Month Performance-2.92%3 Month Performance-12.17%Year-To-Date Performance-48.92%1 Year Performance+31.75% IKT Stock Chart for Saturday, October, 4, 2025 IKT Chart by TradingView Inhibikase Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/03/2025$1.64$1.66+1.22%$1.70$1.5775,316 shs$123.70 million10/02/2025$1.61$1.64+1.86%$1.67$1.5968,184 shs$122.21 million10/01/2025$1.62$1.61-0.62%$1.66$1.5741,581 shs$119.97 million09/30/2025$1.53$1.62+5.88%$1.63$1.50122,750 shs$120.72 million09/29/2025$1.55$1.53-1.29%$1.56$1.5065,193 shs$114.01 million09/26/2025$1.55$1.55$1.60$1.5088,634 shs$115.50 million09/25/2025$1.72$1.55-9.88%$1.72$1.5379,503 shs$115.50 million09/24/2025$1.62$1.72+6.17%$1.75$1.61230,668 shs$128.17 million09/23/2025$1.68$1.62-3.57%$1.72$1.6096,401 shs$120.72 million09/22/2025$1.64$1.68+2.44%$1.70$1.56104,248 shs$125.19 million Get the Latest News and Ratings for IKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/19/2025$1.54$1.64+6.49%$1.78$1.47825,748 shs$122.21 million09/18/2025$1.56$1.54-1.28%$1.61$1.52249,759 shs$114.76 million09/17/2025$1.56$1.56$1.63$1.56107,207 shs$116.25 million09/16/2025$1.60$1.56-2.50%$1.60$1.5557,447 shs$116.25 million09/15/2025$1.56$1.60+2.56%$1.60$1.50157,294 shs$119.23 million09/12/2025$1.68$1.56-7.14%$1.68$1.5578,545 shs$116.25 million09/11/2025$1.54$1.68+9.09%$1.73$1.5097,991 shs$125.19 million09/10/2025$1.67$1.54-7.78%$1.64$1.53107,764 shs$114.76 million09/09/2025$1.66$1.67+0.60%$1.68$1.6033,250 shs$124.44 million09/08/2025$1.67$1.66-0.60%$1.73$1.6548,546 shs$123.70 million09/05/2025$1.71$1.67-2.34%$1.70$1.66209,450 shs$124.44 million09/04/2025$1.73$1.71-1.16%$1.73$1.6675,322 shs$127.42 million09/03/2025$1.76$1.73-1.70%$1.80$1.71113,579 shs$128.91 million Related Companies CYRX Stock Price Chart ETON Stock Price Chart BCYC Stock Price Chart CMPS Stock Price Chart CMPX Stock Price Chart RGNX Stock Price Chart ITOS Stock Price Chart CRVS Stock Price Chart ZYBT Stock Price Chart PRTA Stock Price Chart Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:IKT) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredThese financial titans stride the earth, invisibleUBS says millionaire ranks have surged 5-fold — but many of these new millionaires aren’t tech moguls or Wall ...Porter & Company | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibikase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibikase Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IKT Stock Alerts